植物由来の医薬品有効成分（API）の世界市場レポート 2025年

植物由来の医薬品有効成分（API）市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は6.9％で、423億4,000万米ドルに成長します。予測期間中の成長は、天然医薬品に対する消費者の嗜好の高まり、植物由来の医薬品研究への投資の増加、慢性疾患の治療における用途の拡大、製薬業界と植物薬業界の協力関係の拡大といった要因に起因すると考えられます。この期間の主な動向には、AIを活用した創薬、高度な植物組織培養技術、植物由来化合物の精密発酵、持続可能な生産を目指したグリーン抽出法などがあります。

天然製品やオーガニック製品に対する消費者の需要の高まりが、植物由来の医薬品有効成分（API）市場の成長を牽引すると予想されます。天然・オーガニック製品とは、自然由来の原料を使用し、加工を最小限に抑え、合成化学物質や遺伝子組み換え作物（GMO）を使用していない製品のことです。このような天然・有機製品へのシフトは、合成化学物質に対する健康意識の高まりと懸念によるところが大きく、消費者は合成成分に関連する潜在的リスクをより意識するようになっています。植物由来の医薬品有効成分（API）は、クリーンで安全かつ持続可能なヘルスケアの選択肢を求める消費者の嗜好に沿った、化学物質を含まない効果的な薬効を提供することで、この需要に応えています。例えば2024年5月、アルゼンチンの有機認証機関LETIS S.A.は、2022年の有機食品売上高が616億7,000万米ドルに達し、前期比4.3％増を記録したと報告しました。さらに、その他のオーガニック製品も59億600万米ドルに達し、1.6%の伸びを示しました。その結果、天然およびオーガニック製品への嗜好の高まりが、植物由来の医薬品有効成分（API）市場の拡大に拍車をかけています。

植物由来の医薬品有効成分（API）市場の主要企業は、従来の動物由来原料に代わる持続可能で倫理的な選択肢を提供する植物由来スクアレンなどの革新的ソリューションの開発に注力しています。アマランサス、オリーブ、サトウキビなどの植物由来の植物性スクアレンは、医薬品、化粧品、ワクチンにおいて、サメ由来のスクアレンに代わる倫理的な代替品として機能します。例えば、2023年10月、ドイツを拠点とする特殊化学品会社Evonik Industries AGは、アマランサス油を原料とする初のGMP品質の植物由来スクアレンPhytoSqueneを発売しました。この技術革新は、サメ由来のスクアレンに代わる持続可能な代替品を提供し、高純度、一貫したバッチ品質、欧州薬局方（Ph.Eur.）基準への準拠を保証します。スクアレンは免疫反応を高めるため、ワクチンアジュバントの重要な成分です。植物由来のバージョンを提供することで、PhytoSqueneは生物多様性への懸念に対応し、動物由来の供給源への依存を減らし、文化的・宗教的嗜好を尊重します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界植物由来の医薬品有効成分（API） PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の植物由来の医薬品有効成分（API）市場：成長率分析
• 世界の植物由来の医薬品有効成分（API）市場の実績：規模と成長, 2019-2024
• 世界の植物由来の医薬品有効成分（API）市場の予測：規模と成長, 2024-2029, 2034F
• 世界植物由来の医薬品有効成分（API）総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の植物由来の医薬品有効成分（API）市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アルカロイド
• 配糖体
• カンナビノイド
• フラボノイド
• テルペンとテルペノイド
• ポリフェノール
• サポニン
• その他の製品タイプ
• 世界の植物由来の医薬品有効成分（API）市場：ソース別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 葉
• ルーツ
• 吠える
• 花
• 種子
• 果物
• 樹脂とガム
• その他の情報源
• 世界の植物由来の医薬品有効成分（API）市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オンライン小売業者
• スーパーマーケットまたはハイパーマーケット
• 専門食品店
• フードサービス
• 世界の植物由来の医薬品有効成分（API）市場：最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品
• 栄養補助食品
• ハーブ関連産業
• その他の用途
• 世界の植物由来の医薬品有効成分（API）市場アルカロイドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• モルヒネアルカロイド
• トロパンアルカロイド
• キノリジジンアルカロイド
• インドールアルカロイド
• イソキノリンアルカロイド
• ピロリジジンアルカロイド
• 世界の植物由来の医薬品有効成分（API）市場、配糖体のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 強心配糖体
• アントラキノン配糖体
• フラボノイド配糖体
• サポニン配糖体
• シアン配糖体
• 世界の植物由来の医薬品有効成分（API）市場カンナビノイドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• テトラヒドロカンナビノール（THC）
• カンナビジオール（CBD）
• カンナビゲロール（CBG）
• カンナビクロメン（CBC）
• カンナビノール（CBN）
• 世界の植物由来の医薬品有効成分（API）市場フラボノイドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• フラボン
• フラボノール
• イソフラボン
• フラバノン
• アントシアニン
• 世界の植物由来の医薬品有効成分（API）市場テルペンとテルペノイドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• モノテルペン
• セスキテルペン
• ジテルペン
• トリテルペン
• テトラテルペン
• 世界の植物由来の医薬品有効成分（API）市場ポリフェノールの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• フェノール酸
• スチルベン
• リグナン
• フラボノイドポリフェノール
• 世界の植物由来の医薬品有効成分（API）市場サポニンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ステロイドサポニン
• トリテルペノイドサポニン
• 世界の植物由来の医薬品有効成分（API）市場、その他の製品タイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• クマリン
• タンニン
• リグニン
• フェノール配糖体

第7章 地域別・国別分析

• 世界の植物由来の医薬品有効成分（API）市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の植物由来の医薬品有効成分（API）市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 植物由来の医薬品有効成分（API）市場：競合情勢
• 植物由来の医薬品有効成分（API）市場：企業プロファイル
  • Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
  • Roquette Freres Overview, Products and Services, Strategy and Financial Analysis
  • Sun Pharmaceutical Industries Ltd Overview, Products and Services, Strategy and Financial Analysis
  • Aurobindo Pharma Overview, Products and Services, Strategy and Financial Analysis
  • Koninklijke DSM NV Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Alembic Pharmaceuticals Ltd
• Seppic
• Indena SpA
• PAI Pharma
• Centroflora Group
• Alkaloids Corporation
• SCL Lifesciences Ltd
• Alchem International Pvt Ltd
• AMGIS Lifescience Ltd
• C2 Pharma
• PhytoHealth Corp
• Bright Green Corporation
• Sichuan Xieli Pharmaceutical Co Ltd
• Brains Bioceutical Corp
• Organotechnie

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 植物由来の医薬品有効成分（API）市場2029：新たな機会を提供する国
• 植物由来の医薬品有効成分（API）市場2029：新たな機会を提供するセグメント
• 植物由来の医薬品有効成分（API）市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Plant-based active pharmaceutical ingredients (APIs) are biologically active compounds derived from plants and are essential in the formulation of medications. These ingredients are important for their therapeutic effects, which can include treating, preventing, or managing various health conditions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main product types of plant-based active pharmaceutical ingredients (APIs) include alkaloids, glycosides, cannabinoids, flavonoids, terpenes and terpenoids, polyphenols, saponins, and others. Alkaloids are a diverse group of naturally occurring organic compounds, most of which contain basic nitrogen atoms. Plant-based active pharmaceutical ingredients (APIs) are sourced from various plant parts, including leaves, roots, bark, flowers, seeds, fruits, resins, gums, and other natural sources. These ingredients are distributed through various channels, such as online retailers, supermarkets and hypermarkets, specialty food stores, and foodservice providers, and are widely used across industries such as pharmaceuticals, nutraceuticals, herbal-based industries, and others.

The plant-based active pharmaceutical ingredients (API) market research report is one of a series of new reports from The Business Research Company that provides plant-based active pharmaceutical ingredients (API) market statistics, including plant-based active pharmaceutical ingredients (API) industry global market size, regional shares, competitors with a plant-based active pharmaceutical ingredients (API) market share, detailed plant-based active pharmaceutical ingredients (API) market segments, market trends and opportunities, and any further data you may need to thrive in the plant-based active pharmaceutical ingredients (API) industry. This plant-based active pharmaceutical ingredients (API) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The plant-based active pharmaceutical ingredients (API) market size has grown strongly in recent years. It will grow from$30.22 billion in 2024 to $32.39 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth during the historic period can be attributed to factors such as the increasing use of traditional herbal medicine practices, a growing demand for natural remedies, the rise of early pharmaceutical formulations, the expanding global trade of medicinal herbs, and the increasing industrialization of botanical drugs.

The plant-based active pharmaceutical ingredients (API) market size is expected to see strong growth in the next few years. It will grow to$42.34 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth during the forecast period can be attributed to factors such as rising consumer preference for natural medicines, increasing investment in plant-based drug research, expanding applications in the treatment of chronic diseases, and growing collaborations between the pharmaceutical and botanical industries. Key trends during this period include AI-driven drug discovery, advanced plant tissue culture techniques, precision fermentation for plant-derived compounds, and green extraction methods aimed at sustainable production.

The rising consumer demand for natural and organic products is expected to drive the growth of the plant-based active pharmaceutical ingredients (API) market. Natural and organic products are those made from ingredients that are naturally sourced, minimally processed, and free from synthetic chemicals and genetically modified organisms (GMOs). This shift towards natural and organic products is largely due to increased health awareness and concerns over synthetic chemicals, with consumers becoming more conscious of the potential risks associated with synthetic ingredients. Plant-based active pharmaceutical ingredients (APIs) cater to this demand by providing effective, chemical-free medicinal benefits that align with the consumer preference for clean, safe, and sustainable healthcare options. For example, in May 2024, LETIS S.A., an Argentina-based organic certification authority, reported that organic food sales reached $61.67 billion in 2022, marking a 4.3% increase from the previous period. Additionally, other organic products contributed $5.906 billion, reflecting a 1.6% growth. As a result, the growing preference for natural and organic products is fueling the expansion of the plant-based active pharmaceutical ingredients (API) market.

Leading companies in the plant-based active pharmaceutical ingredients (API) market are focusing on developing innovative solutions such as plant-based squalene, which offer sustainable and ethical alternatives to traditional animal-derived sources. Plant-based squalene, derived from plants such as amaranth, olives, and sugarcane, serves as an ethical substitute for shark-derived squalene in pharmaceuticals, cosmetics, and vaccines. For instance, in October 2023, Evonik Industries AG, a Germany-based specialty chemicals company, launched PhytoSquene, the first GMP-quality, plant-based squalene sourced from amaranth oil. This innovation provides a sustainable alternative to shark-derived squalene, ensuring high purity, consistent batch quality, and compliance with European Pharmacopoeia (Ph. Eur.) standards. Squalene is an important ingredient in vaccine adjuvants, as it enhances the immune response. By offering a plant-based version, PhytoSquene addresses concerns about biodiversity, reduces reliance on animal-derived sources, and respects cultural and religious preferences.

In March 2024, Roquette Freres, a France-based provider of pharmaceutical excipients, acquired IFF Pharma Solutions for an undisclosed sum. This acquisition aims to strengthen Roquette's position in the pharmaceutical excipients market by broadening its product portfolio and expertise in drug delivery. This move is expected to accelerate Roquette's growth in the health and nutrition sectors, positioning the company as a key partner for pharmaceutical companies. IFF Pharma Solutions, a US-based pharmaceutical company, specializes in offering plant-based active pharmaceutical ingredients.

Major players in the plant-based active pharmaceutical ingredients (API) market are Evonik Industries AG, Roquette Freres, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma, Koninklijke DSM NV, Alembic Pharmaceuticals Ltd, Seppic, Indena SpA, PAI Pharma, Centroflora Group, Alkaloids Corporation, SCL Lifesciences Ltd, Alchem International Pvt Ltd, AMGIS Lifescience Ltd, C2 Pharma, PhytoHealth Corp, Bright Green Corporation, Sichuan Xieli Pharmaceutical Co Ltd, Brains Bioceutical Corp, Organotechnie, and HimPharm.

North America was the largest region in the plant-based active pharmaceutical ingredients (API) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in plant-based active pharmaceutical ingredients (API) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the plant-based active pharmaceutical ingredients (API) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The plant-based active pharmaceutical ingredients (API) market consists of sales of botanical extracts, plant-based steroids, essential oils, flavonoids, and botanical extracts. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Plant-Based Active Pharmaceutical Ingredients (API) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on plant-based active pharmaceutical ingredients (api) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for plant-based active pharmaceutical ingredients (api) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The plant-based active pharmaceutical ingredients (api) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Alkaloids; Glycosides; Cannabinoids; Flavonoid; Terpenes And Terpenoids; Polyphenols; Saponins; Other Product Types
• 2) By Source: Leaves; Roots; Bark; Flowers; Seeds; Fruits; Resin And Gums; Other Sources
• 3) By Distribution Channel: Online Retailers; Supermarkets Or Hypermarkets; Specialty Food Stores; Foodservice
• 4) By End-Use: Pharmaceuticals; Nutraceuticals; Herbal Based Industries; Other End-Uses
• Subsegments:
• 1) Alkaloids: Morphine Alkaloids; Tropane Alkaloids; Quinolizidine Alkaloids; Indole Alkaloids; Isoquinoline Alkaloids; Pyrrolizidine Alkaloids
• 2) By Glycosides: Cardiac Glycosides; Anthraquinone Glycosides; Flavonoid Glycosides; Saponin Glycosides; Cyanogenic Glycosides
• 3) Cannabinoids: Tetrahydrocannabinol (THC); Cannabidiol (CBD); Cannabigerol (CBG); Cannabichromene (CBC); Cannabinol (CBN)
• 4) Flavonoid: Flavones; Flavonols; Isoflavones; Flavanones; Anthocyanins
• 5) Terpenes And Terpenoids: Monoterpenes; Sesquiterpenes; Diterpenes; Triterpenes; Tetraterpenes
• 6) Polyphenols: Phenolic Acids; Stilbenes; Lignans; Flavonoid Polyphenols
• 7) Saponins: Steroidal Saponins; Triterpenoid Saponins
• 8) Other Product Types: Coumarins; Tannins; Lignins; Phenolic Glycosides
• Companies Mentioned: Evonik Industries AG; Roquette Freres; Sun Pharmaceutical Industries Ltd; Aurobindo Pharma; Koninklijke DSM NV
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Plant-Based Active Pharmaceutical Ingredients (API) Market Characteristics

3. Plant-Based Active Pharmaceutical Ingredients (API) Market Trends And Strategies

4. Plant-Based Active Pharmaceutical Ingredients (API) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Plant-Based Active Pharmaceutical Ingredients (API) Growth Analysis And Strategic Analysis Framework

• 5.1. Global Plant-Based Active Pharmaceutical Ingredients (API) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Plant-Based Active Pharmaceutical Ingredients (API) Market Growth Rate Analysis
• 5.4. Global Plant-Based Active Pharmaceutical Ingredients (API) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Plant-Based Active Pharmaceutical Ingredients (API) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Plant-Based Active Pharmaceutical Ingredients (API) Total Addressable Market (TAM)

6. Plant-Based Active Pharmaceutical Ingredients (API) Market Segmentation

• 6.1. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alkaloids
• Glycosides
• Cannabinoids
• Flavonoid
• Terpenes And Terpenoids
• Polyphenols
• Saponins
• Other Product Types
• 6.2. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Leaves
• Roots
• Bark
• Flowers
• Seeds
• Fruits
• Resin And Gums
• Other Sources
• 6.3. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Online Retailers
• Supermarkets Or Hypermarkets
• Specialty Food Stores
• Foodservice
• 6.4. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceuticals
• Nutraceuticals
• Herbal Based Industries
• Other End-Uses
• 6.5. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Sub-Segmentation Of Alkaloids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Morphine Alkaloids
• Tropane Alkaloids
• Quinolizidine Alkaloids
• Indole Alkaloids
• Isoquinoline Alkaloids
• Pyrrolizidine Alkaloids
• 6.6. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Sub-Segmentation Of Glycosides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiac Glycosides
• Anthraquinone Glycosides
• Flavonoid Glycosides
• Saponin Glycosides
• Cyanogenic Glycosides
• 6.7. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Sub-Segmentation Of Cannabinoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tetrahydrocannabinol (THC)
• Cannabidiol (CBD)
• Cannabigerol (CBG)
• Cannabichromene (CBC)
• Cannabinol (CBN)
• 6.8. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Sub-Segmentation Of Flavonoid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Flavones
• Flavonols
• Isoflavones
• Flavanones
• Anthocyanins
• 6.9. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Sub-Segmentation Of Terpenes And Terpenoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monoterpenes
• Sesquiterpenes
• Diterpenes
• Triterpenes
• Tetraterpenes
• 6.10. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Sub-Segmentation Of Polyphenols, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Phenolic Acids
• Stilbenes
• Lignans
• Flavonoid Polyphenols
• 6.11. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Sub-Segmentation Of Saponins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Steroidal Saponins
• Triterpenoid Saponins
• 6.12. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Coumarins
• Tannins
• Lignins
• Phenolic Glycosides

7. Plant-Based Active Pharmaceutical Ingredients (API) Market Regional And Country Analysis

• 7.1. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Plant-Based Active Pharmaceutical Ingredients (API) Market

• 8.1. Asia-Pacific Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Plant-Based Active Pharmaceutical Ingredients (API) Market

• 9.1. China Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• 9.2. China Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Plant-Based Active Pharmaceutical Ingredients (API) Market

• 10.1. India Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Plant-Based Active Pharmaceutical Ingredients (API) Market

• 11.1. Japan Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• 11.2. Japan Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Plant-Based Active Pharmaceutical Ingredients (API) Market

• 12.1. Australia Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Plant-Based Active Pharmaceutical Ingredients (API) Market

• 13.1. Indonesia Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Plant-Based Active Pharmaceutical Ingredients (API) Market

• 14.1. South Korea Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• 14.2. South Korea Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Plant-Based Active Pharmaceutical Ingredients (API) Market

• 15.1. Western Europe Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• 15.2. Western Europe Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Plant-Based Active Pharmaceutical Ingredients (API) Market

• 16.1. UK Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Plant-Based Active Pharmaceutical Ingredients (API) Market

• 17.1. Germany Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Plant-Based Active Pharmaceutical Ingredients (API) Market

• 18.1. France Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Plant-Based Active Pharmaceutical Ingredients (API) Market

• 19.1. Italy Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Plant-Based Active Pharmaceutical Ingredients (API) Market

• 20.1. Spain Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Plant-Based Active Pharmaceutical Ingredients (API) Market

• 21.1. Eastern Europe Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• 21.2. Eastern Europe Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Plant-Based Active Pharmaceutical Ingredients (API) Market

• 22.1. Russia Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Plant-Based Active Pharmaceutical Ingredients (API) Market

• 23.1. North America Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• 23.2. North America Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Plant-Based Active Pharmaceutical Ingredients (API) Market

• 24.1. USA Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• 24.2. USA Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Plant-Based Active Pharmaceutical Ingredients (API) Market

• 25.1. Canada Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• 25.2. Canada Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Plant-Based Active Pharmaceutical Ingredients (API) Market

• 26.1. South America Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• 26.2. South America Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Plant-Based Active Pharmaceutical Ingredients (API) Market

• 27.1. Brazil Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Plant-Based Active Pharmaceutical Ingredients (API) Market

• 28.1. Middle East Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• 28.2. Middle East Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Plant-Based Active Pharmaceutical Ingredients (API) Market

• 29.1. Africa Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• 29.2. Africa Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Plant-Based Active Pharmaceutical Ingredients (API) Market Competitive Landscape And Company Profiles

• 30.1. Plant-Based Active Pharmaceutical Ingredients (API) Market Competitive Landscape
• 30.2. Plant-Based Active Pharmaceutical Ingredients (API) Market Company Profiles
  • 30.2.1. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Roquette Freres Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sun Pharmaceutical Industries Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Aurobindo Pharma Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Koninklijke DSM NV Overview, Products and Services, Strategy and Financial Analysis

31. Plant-Based Active Pharmaceutical Ingredients (API) Market Other Major And Innovative Companies

• 31.1. Alembic Pharmaceuticals Ltd
• 31.2. Seppic
• 31.3. Indena SpA
• 31.4. PAI Pharma
• 31.5. Centroflora Group
• 31.6. Alkaloids Corporation
• 31.7. SCL Lifesciences Ltd
• 31.8. Alchem International Pvt Ltd
• 31.9. AMGIS Lifescience Ltd
• 31.10. C2 Pharma
• 31.11. PhytoHealth Corp
• 31.12. Bright Green Corporation
• 31.13. Sichuan Xieli Pharmaceutical Co Ltd
• 31.14. Brains Bioceutical Corp
• 31.15. Organotechnie

32. Global Plant-Based Active Pharmaceutical Ingredients (API) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Plant-Based Active Pharmaceutical Ingredients (API) Market

34. Recent Developments In The Plant-Based Active Pharmaceutical Ingredients (API) Market

35. Plant-Based Active Pharmaceutical Ingredients (API) Market High Potential Countries, Segments and Strategies

• 35.1 Plant-Based Active Pharmaceutical Ingredients (API) Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Plant-Based Active Pharmaceutical Ingredients (API) Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Plant-Based Active Pharmaceutical Ingredients (API) Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250617_r34929_Plant_Based_Active_Pharmaceutical_Ingredients_API_GMR_2025